Diabetes Emergency Relief Coalition Wins Top Association Honor

ASAE recognizes coalition partners’ hurricane relief work with 2018 Summit Power of A Award. WASHINGTON (June 25, 2018) —The Diabetes Emergency Relief Coalition (Coalition), composed of leading diabetes care and research organizations, will receive the American Society of Association Executives (ASAE) 2018 Summit Power of A Award for helping to provide critical diabetes supplies to [...]

2018-06-25T16:16:40+00:00 June 25th, 2018|News|

Endocrinologist and Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange

Dr. Schuster comes to T1D Exchange from Eli Lilly and Company, where she launched the company’s diabetes real-world evidence partnership development program. Press Release Boston, MA – June 22, 2018– T1D Exchange, a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today announced that Endocrinologist Dara P. [...]

2018-06-22T08:58:30+00:00 June 22nd, 2018|News|

Innovators From 17 Countries Vie for $250,000 in Prizes Advancing Diabetes Care In the 2018 Diabetes Innovation Challenge

Submissions include research to develop new insulin delivery technologies, therapeutics, diagnostics, and digital app-based tools to improve outcomes Boston, MA – March 20, 2018 – T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type 1 diabetes (T1D), today announced that 60 academic [...]

2018-04-12T06:11:09+00:00 April 12th, 2018|News|

T1D Exchange Officially Opens the 2018 Diabetes Innovation Challenge Call for Applications

Global Challenge Launched to Identify, Present and Award the Next Breakthrough Solutions for Diabetes Care Boston, MA—November 28, 2017—T1D Exchange, a Boston-based nonprofit organization dedicated to accelerating therapies and improving care in type 1 diabetes, opened the Call for Applications for the 2018 Diabetes Innovation Challenge, a global competition to identify, nurture and fast-track innovative [...]

2018-04-12T06:21:50+00:00 November 28th, 2017|News|

T1D Exchange Joins Leading Diabetes Organizations and Issues Consensus Statement

Leading Diabetes Organizations Issue Consensus Statement Defining Health Outcomes beyond HbA1c The Type 1 Diabetes Outcomes Program, organized by JDRF, has identified and defined clinically meaningful T1D outcomes other than the standard measure of HbA1c. A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines [...]

2017-11-22T12:12:38+00:00 November 22nd, 2017|News|

Dr. Alicia H. McAuliffe-Fogarty Named Vice President of Patient Research for T1D Exchange

Proven leader will oversee research program designed to incorporate patient-reported experiences to impact research, clinical care, and outcomes BOSTON, MA, August 15, 2017 – Alicia H. McAuliffe-Fogarty, PhD, CPsychol has been named vice president of patient-centered research for T1D Exchange, a Boston-based nonprofit organization uniting those affected by disease with those dedicated to accelerating [...]

2018-04-12T06:25:55+00:00 August 15th, 2017|News|

T1D Exchange Invests in Breakthrough Startup Admetsys to Improve Diabetes Care during Hospitalization

Effort Aims to Accelerate Development of the Admetsys Automated Insulin Delivery System for Hospitals and Surgical Centers BOSTON, MA, June 6, 2017 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the organization has invested in Admetsys, the first company to develop an artificial pancreas [...]

2017-06-06T09:16:08+00:00 June 6th, 2017|News|

T1D Exchange Adds Strategic Leadership to Board and Team in Response to Organizational Growth

BOSTON, MA, April 11, 2016 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the election of a new Board member and the addition of three executives to its leadership team. These additions demonstrate the organization’s rapid growth as it continues to build strategic initiatives [...]

2017-04-10T13:58:12+00:00 April 11th, 2017|News|

REPLACE BG: A T1D Exchange Study Confirms Continuous Glucose Monitoring (CGM) Alone is as Safe and Effective as CGM with Blood Glucose Monitoring

T1D Exchange recently published the results of a major study that confirms the use of Continuous Glucose Monitoring (CGM) without regular use of confirmatory Blood Glucose Measurements (BGM) is as safe and effective as use of CGM with confirmatory BGM. This multi-center study enrolled 226 adults with type 1 diabetes (T1D). All study participants were [...]

2017-03-31T08:50:31+00:00 March 20th, 2017|News|